M&T Bank Corp Emergent Bio Solutions Inc. Transaction History
M&T Bank Corp
- $231 Billion
- Q4 2024
Shares
20 transactions
Others Institutions Holding EBS
# of Institutions
168Shares Held
36.3MCall Options Held
352KPut Options Held
770K-
Black Rock Inc. New York, NY3.84MShares$37.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.2MShares$31.1 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO2.14MShares$20.8 Million0.01% of portfolio
-
State Street Corp Boston, MA1.96MShares$19.1 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$15 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $485M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...